医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Inter Partner Assistance Hong Kong Ltd. Forms a Partnership With The CareVoice To Provide Fully Digital Health Journeys and Integrated Healthcare Solutions to the Hong Kong Health Insurance Market

2018年09月27日 AM10:05
このエントリーをはてなブックマークに追加


 

HONG KONG

Inter Partner Assistance Hong Kong Ltd. has partnered with The CareVoice to provide fully digital health journeys and integrated healthcare solutions to the insurance market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180926005325/en/

The fully digital and integrated health insurance customer journey. (Photo: Business Wire)

The fully digital and integrated health insurance customer journey. (Photo: Business Wire)

Inter Partner Assistance Hong Kong Ltd. maintains an extensive hospital network and has over 25 years of experience in managing IPMI claims and providing emergency assistance 24/7. Inter Partner Assistance Hong Kong Ltd. already provides claim adjudication and assistance services to a majority of the Health and Travel insurance companies in Hong Kong.

The CareVoice is an award-winning Shanghai based health InsurTech company which perfectly complements Inter Partner Assistance Hong Kong Ltd.’s footprint by adding a mobile-based and data-driven SaaS solution that digitalizes the healthcare and insurance journey with consumer’s interests first.

“We are confident that our partnership with The CareVoice will provide new advantages for our healthcare partners and continue to accelerate our healthcare innovations by providing end customers with a transparent, integrated and personalized healthcare experience.” said Joseph Lee, CEO of Inter Partner Assistance Hong Kong Ltd.

The CareVoice’s independent mobile SaaS platform breaks down barriers to bring easy healthcare navigation. Their unique platform also helps insurers to become true health partners to their customers by offering cutting edge innovations such as an AI voice-based Virtual Health Assistant for symptoms checker, powered by Sense.ly, with medical content originated from the Mayo Clinic.

The partnership focuses on the following areas to deliver value:

1. Empower insurance partners with cutting edge innovation for their customers.

  • Integrated platform adaptable to different environments (mobile app, web app, WeChat account) and operational in multiple languages.
  • Fully digitalized customer journey within one mobile experience.
  • Access to a voice-based Virtual Health Assistant powered by artificial intelligence.

2. Bring partners closer to their customers.

  • Clearly and precisely explain medical insurance benefits.
  • Engage with customers through personalized digital and health services.
  • Reward customers when being physically active and selecting high quality cost-effective medical providers.

3. Drive efficiency and lower operational costs.

  • Reduce unnecessary medical consultations by utilizing the Virtual Health Assistant’s symptom checker and triage.
  • Adopt a fully digitalized hotline and e-claims reimbursement process.
  • Receive actionable insights and data from anonymized customer usage behavior and post-claim surveys.

About Inter Partner Assistance Hong Kong Ltd.

Inter Partner Assistance Hong Kong Ltd. has specialized in providing assistance, travel and health services since 1992. With access to a Group proprietary network of 37 Alarm Centers and more than 6,500 correspondents worldwide, Inter Partner Assistance Hong Kong Ltd. has since demonstrated its ability to be instantly reactive and effective in all circumstances, anywhere in the world, 24 hours a day.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180926005325/en/

CONTACT

Inter Partner Assistance Hong Kong Ltd.
Joseph LEE,
CEO
T
+852 2851 0620
joseph.lee@ip-assistance.com

同じカテゴリーの記事 

  • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
  • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
  • Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China